Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Opioid use disorder during pregnancy: An overview.

Carter LC, Read MA, Read L, Nicholas JS, Schmidt E.

JAAPA. 2019 Mar;32(3):20-24. doi: 10.1097/01.JAA.0000553378.44766.1d.

PMID:
30741850
2.

Implementing School-Based Policies to Prevent Obesity: Cluster Randomized Trial.

Ickovics JR, Duffany KO, Shebl FM, Peters SM, Read MA, Gilstad-Hayden KR, Schwartz MB.

Am J Prev Med. 2019 Jan;56(1):e1-e11. doi: 10.1016/j.amepre.2018.08.026.

PMID:
30573151
3.

Impact of the Smoothened inhibitor, IPI-926, on smoothened ciliary localization and Hedgehog pathway activity.

Peluso MO, Campbell VT, Harari JA, Tibbitts TT, Proctor JL, Whitebread N, Conley JM, White KF, Kutok JL, Read MA, McGovern K, Faia KL.

PLoS One. 2014 Mar 7;9(3):e90534. doi: 10.1371/journal.pone.0090534. eCollection 2014.

4.

First record of sea snake (Hydrophis elegans, Hydrophiinae) entrapped in marine debris.

Udyawer V, Read MA, Hamann M, Simpfendorfer CA, Heupel MR.

Mar Pollut Bull. 2013 Aug 15;73(1):336-8. doi: 10.1016/j.marpolbul.2013.06.023. Epub 2013 Jun 26.

PMID:
23809333
5.

Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus.

Shimp SK 3rd, Chafin CB, Regna NL, Hammond SE, Read MA, Caudell DL, Rylander M, Reilly CM.

Cell Mol Immunol. 2012 May;9(3):255-66. doi: 10.1038/cmi.2012.5. Epub 2012 Apr 30.

6.

Estuarine crocodiles ride surface currents to facilitate long-distance travel.

Campbell HA, Watts ME, Sullivan S, Read MA, Choukroun S, Irwin SR, Franklin CE.

J Anim Ecol. 2010 Sep;79(5):955-64. doi: 10.1111/j.1365-2656.2010.01709.x. Epub 2010 Jun 7.

PMID:
20546063
7.

New developments in the discovery of small molecule Hedgehog pathway antagonists.

Tremblay MR, McGovern K, Read MA, Castro AC.

Curr Opin Chem Biol. 2010 Jun;14(3):428-35. doi: 10.1016/j.cbpa.2010.03.016.

PMID:
20399136
8.

Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926).

Tremblay MR, Lescarbeau A, Grogan MJ, Tan E, Lin G, Austad BC, Yu LC, Behnke ML, Nair SJ, Hagel M, White K, Conley J, Manna JD, Alvarez-Diez TM, Hoyt J, Woodward CN, Sydor JR, Pink M, MacDougall J, Campbell MJ, Cushing J, Ferguson J, Curtis MS, McGovern K, Read MA, Palombella VJ, Adams J, Castro AC.

J Med Chem. 2009 Jul 23;52(14):4400-18. doi: 10.1021/jm900305z.

PMID:
19522463
9.

Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonists.

Tremblay MR, Nevalainen M, Nair SJ, Porter JR, Castro AC, Behnke ML, Yu LC, Hagel M, White K, Faia K, Grenier L, Campbell MJ, Cushing J, Woodward CN, Hoyt J, Foley MA, Read MA, Sydor JR, Tong JK, Palombella VJ, McGovern K, Adams J.

J Med Chem. 2008 Nov 13;51(21):6646-9. doi: 10.1021/jm8008508. Epub 2008 Oct 9.

PMID:
18842035
10.
11.

Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90.

Sydor JR, Normant E, Pien CS, Porter JR, Ge J, Grenier L, Pak RH, Ali JA, Dembski MS, Hudak J, Patterson J, Penders C, Pink M, Read MA, Sang J, Woodward C, Zhang Y, Grayzel DS, Wright J, Barrett JA, Palombella VJ, Adams J, Tong JK.

Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17408-13. Epub 2006 Nov 7.

12.

Microvascular effects of corticotropin-releasing hormone in human skin vary in relation to estrogen concentration during the menstrual cycle.

Clifton VL, Crompton R, Read MA, Gibson PG, Smith R, Wright IM.

J Endocrinol. 2005 Jul;186(1):69-76.

PMID:
16002537
13.

Evaluation of by disubstituted acridone derivatives as telomerase inhibitors: the importance of G-quadruplex binding.

Harrison RJ, Reszka AP, Haider SM, Romagnoli B, Morrell J, Read MA, Gowan SM, Incles CM, Kelland LR, Neidle S.

Bioorg Med Chem Lett. 2004 Dec 6;14(23):5845-9.

PMID:
15501053
16.

Corticotropin-releasing hormone causes vasodilation in human skin via mast cell-dependent pathways.

Crompton R, Clifton VL, Bisits AT, Read MA, Smith R, Wright IM.

J Clin Endocrinol Metab. 2003 Nov;88(11):5427-32.

PMID:
14602784
17.

Trisubstituted acridine derivatives as potent and selective telomerase inhibitors.

Harrison RJ, Cuesta J, Chessari G, Read MA, Basra SK, Reszka AP, Morrell J, Gowan SM, Incles CM, Tanious FA, Wilson WD, Kelland LR, Neidle S.

J Med Chem. 2003 Oct 9;46(21):4463-76.

PMID:
14521409
18.

The design of G-quadruplex ligands as telomerase inhibitors.

Cuesta J, Read MA, Neidle S.

Mini Rev Med Chem. 2003 Feb;3(1):11-21. Review.

PMID:
12570851
19.

Estrogen represses whereas the estrogen-antagonist ICI 182780 stimulates placental CRH gene expression.

Ni X, Nicholson RC, King BR, Chan EC, Read MA, Smith R.

J Clin Endocrinol Metab. 2002 Aug;87(8):3774-8.

PMID:
12161509
20.

A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity.

Gowan SM, Harrison JR, Patterson L, Valenti M, Read MA, Neidle S, Kelland LR.

Mol Pharmacol. 2002 May;61(5):1154-62.

PMID:
11961134
21.

An intact NEDD8 pathway is required for Cullin-dependent ubiquitylation in mammalian cells.

Ohh M, Kim WY, Moslehi JJ, Chen Y, Chau V, Read MA, Kaelin WG Jr.

EMBO Rep. 2002 Feb;3(2):177-82. Epub 2002 Jan 29.

22.

G-quadruplexes as therapeutic targets.

Neidle S, Read MA.

Biopolymers. 2000-2001;56(3):195-208. Review.

PMID:
11745111
23.

Vasoactive effects of 8-epi-prostaglandin F(2alpha)in isolated human placental conduit and resistance blood vessels in vitro.

Kwek K, Read MA, Khong TY, Bisits AT, Walters WA.

Placenta. 2001 Jul;22(6):526-33.

PMID:
11440540
24.

Dietary n-3 fatty acids alter the contractile response to thromboxane A(2) agonists of porcine coronary arteries.

Read MA, Leitch JW, Osmond D, Quagiotto P, Falconer J, Garg ML.

J Nutr Biochem. 2001 May;12(5):258-265.

PMID:
11382543
25.

Effects of nitrovasodilators on the human fetal-placental circulation in vitro.

Zhang XQ, Kwek K, Read MA, Donoghue JF, Walters WA.

Placenta. 2001 Apr;22(4):337-46.

PMID:
11286570
26.

Structural characterization of a guanine-quadruplex ligand complex.

Read MA, Neidle S.

Biochemistry. 2000 Nov 7;39(44):13422-32.

PMID:
11063579
27.

A novel inhibitor of human telomerase derived from 10H-indolo[3,2-b]quinoline.

Caprio V, Guyen B, Opoku-Boahen Y, Mann J, Gowan SM, Kelland LM, Read MA, Neidle S.

Bioorg Med Chem Lett. 2000 Sep 18;10(18):2063-6.

PMID:
10999471
28.

Fetal placental vascular responses to corticotropin-releasing hormone in vitro. Effects of variation in oxygen tension.

Donoghue JF, Leitch IM, Boura AL, Walters WA, Giles WB, Smith R, Read MA.

Placenta. 2000 Sep;21(7):711-7.

PMID:
10985975
29.

Evidence for a hormonal tactic maximizing green turtle reproduction in response to a pervasive ecological stressor.

Jessop TS, Hamann M, Read MA, Limpus CJ.

Gen Comp Endocrinol. 2000 Jun;118(3):407-17.

PMID:
10843792
30.

Structure-activity relationships among guanine-quadruplex telomerase inhibitors.

Neidle S, Harrison RJ, Reszka AP, Read MA.

Pharmacol Ther. 2000 Mar;85(3):133-9. Review.

PMID:
10739868
31.

Nedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent ubiquitination of IkappaBalpha.

Read MA, Brownell JE, Gladysheva TB, Hottelet M, Parent LA, Coggins MB, Pierce JW, Podust VN, Luo RS, Chau V, Palombella VJ.

Mol Cell Biol. 2000 Apr;20(7):2326-33.

32.

Design, synthesis and evaluation of human telomerase inhibitors based upon a tetracyclic structural motif.

Perry PJ, Gowan SM, Read MA, Kelland LR, Neidle S.

Anticancer Drug Des. 1999 Aug;14(4):373-82.

PMID:
10625930
33.

Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors: structure-activity relationships.

Read MA, Wood AA, Harrison JR, Gowan SM, Kelland LR, Dosanjh HS, Neidle S.

J Med Chem. 1999 Nov 4;42(22):4538-46.

PMID:
10579817
34.

Crystal structure of human DT-diaphorase: a model for interaction with the cytotoxic prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954).

Skelly JV, Sanderson MR, Suter DA, Baumann U, Read MA, Gregory DS, Bennett M, Hobbs SM, Neidle S.

J Med Chem. 1999 Oct 21;42(21):4325-30.

PMID:
10543876
35.

Stabilization of DNA triple helices by a series of mono- and disubstituted amidoanthraquinones.

Keppler MD, Read MA, Perry PJ, Trent JO, Jenkins TC, Reszka AP, Neidle S, Fox KR.

Eur J Biochem. 1999 Aug;263(3):817-25.

36.

A new model of cancer cachexia: contribution of the ubiquitin-proteasome pathway.

Lazarus DD, Destree AT, Mazzola LM, McCormack TA, Dick LR, Xu B, Huang JQ, Pierce JW, Read MA, Coggins MB, Solomon V, Goldberg AL, Brand SJ, Elliott PJ.

Am J Physiol. 1999 Aug;277(2):E332-41. doi: 10.1152/ajpendo.1999.277.2.E332.

PMID:
10444430
37.

2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase.

Perry PJ, Read MA, Davies RT, Gowan SM, Reszka AP, Wood AA, Kelland LR, Neidle S.

J Med Chem. 1999 Jul 15;42(14):2679-84.

PMID:
10411488
38.
39.

U46619-mediated vasoconstriction of the fetal placental vasculature in vitro in normal and hypertensive pregnancies.

Read MA, Leitch IM, Giles WB, Bisits AM, Boura AL, Walters WA.

J Hypertens. 1999 Mar;17(3):389-96.

PMID:
10100077
40.

Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro.

Leitch IM, Boura AL, Botti C, Read MA, Walters WA, Smith R.

J Clin Endocrinol Metab. 1998 Dec;83(12):4510-3.

PMID:
9851801
41.

Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones.

Perry PJ, Reszka AP, Wood AA, Read MA, Gowan SM, Dosanjh HS, Trent JO, Jenkins TC, Kelland LR, Neidle S.

J Med Chem. 1998 Nov 19;41(24):4873-84.

PMID:
9822556
42.

Effects of Bufo marinus skin toxins on human fetal extracorporeal blood vessels.

Lim TH, Leitch IM, Boura AL, Read MA, Walters WA.

Toxicon. 1997 Feb;35(2):293-304.

PMID:
9080586
43.
44.

Postinduction transcriptional repression of E-selectin and vascular cell adhesion molecule-1.

Read MA, Neish AS, Gerritsen ME, Collins T.

J Immunol. 1996 Oct 15;157(8):3472-9.

PMID:
8871646
45.

Actions of magnesium, nifedipine and clonidine on the fetal vasculature of the human placenta.

David R, Leitch IM, Read MA, Boura AL, Walters WA.

Aust N Z J Obstet Gynaecol. 1996 Aug;36(3):267-71.

PMID:
8883748
46.

Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration.

Pierce JW, Read MA, Ding H, Luscinskas FW, Collins T.

J Immunol. 1996 May 15;156(10):3961-9.

PMID:
8621937
47.

Adrenocorticotropin causes vasodilatation in the human fetal-placental circulation.

Clifton VL, Read MA, Boura AL, Robinson PJ, Smith R.

J Clin Endocrinol Metab. 1996 Apr;81(4):1406-10.

PMID:
8636342
48.
49.

Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3',5'-monophosphate-mediated pathway.

Clifton VL, Read MA, Leitch IM, Giles WB, Boura AL, Robinson PJ, Smith R.

J Clin Endocrinol Metab. 1995 Oct;80(10):2888-93.

PMID:
7559870
50.

Flavonoids: naturally occurring anti-inflammatory agents.

Read MA.

Am J Pathol. 1995 Aug;147(2):235-7. No abstract available.

Supplemental Content

Support Center